Abstract

BackgroundGrifolic acid is a derivative of grifolin, an antitumor natural compound, and it was reported as an agonist of free fatty acid receptor GPR120. Little is known about its antitumor effects and the involvement of GPR120.MethodsGH3 cells, the rat anterior pituitary adenoma cells, were cultured and the cell death was measured by MTT assay and Annexin V/PI staining. The mitochondrial membrane potential (MMP) of GH3 cells was measured by JC-1 staining. Cellular ATP levels and the intracellular NAD/NADH ratio were measured. GPR120 expression in GH3 cells was observed by RT-PCR and Western Blot, and siRNA was used to inhibit GPR120 expression in GH3 cells.ResultsGrifolic acid dose- and time-dependently induced the necrosis of GH3 cells. Grifolic acid significantly reduced the mitochondrial membrane potential (MMP) and decreased cellular ATP levels in GH3 cells. In contrast, the MMP of isolated mitochondria was not decreased by grifolic acid. The intracellular NAD/NADH ratio was significantly increased by grifolic acid. GPR120 is expressed in GH3 cells, but GPR120 agonists such as EPA, GW9508 and TUG891 did not affect the viability of GH3 cells. Moreover, GPR120 siRNA knockdown showed no significant influence on grifolic acid-induced GH3 cell death.ConclusionGrifolic acid induces GH3 cell death by decreasing MMP and inhibiting ATP production, which may be due to the inhibition of NADH production through a GPR120-independent mechanism.

Highlights

  • Grifolic acid is a derivative of grifolin, an antitumor natural compound, and it was reported as an agonist of free fatty acid receptor G protein-coupled receptor 120 (GPR120)

  • It is well known that grifolin, one of the natural compounds isolated from the fresh fruiting bodies of the mushroom Albatrellus confluens [2], exhibits antitumor effects on nasopharyngeal carcinoma, osteosarcoma, and gastric tumor cells [3,4,5]

  • AnnexinV/PI staining and the flow cytometry analysis was used to observe the death of GH3 cells

Read more

Summary

Introduction

Grifolic acid is a derivative of grifolin, an antitumor natural compound, and it was reported as an agonist of free fatty acid receptor GPR120. Some natural compounds, which are isolated from botany, fungi and marine organism, are putative candidates for antitumor drugs [1]. It is well known that grifolin, one of the natural compounds isolated from the fresh fruiting bodies of the mushroom Albatrellus confluens [2], exhibits antitumor effects on nasopharyngeal carcinoma, osteosarcoma, and gastric tumor cells [3,4,5]. Grifolic acid (the structure in Additional file 1) is a derivative of grifolin, but its effects on tumor cells are not well. New. Zhao et al BMC Pharmacology and Toxicology (2018) 19:26 effective antitumor drugs may significantly improve the therapy of anterior pituitary adenomas. We observed the effects of grifolic acid on the viability of GH3 cells, the rat anterior pituitary adenoma cells that secret growth hormone and prolactin [11]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call